Literature DB >> 18247079

Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic.

S Forejtová1, H Mann, J Stolfa, K Vedral, I Fenclová, D Némethová, K Pavelka.   

Abstract

The aim of the study was to evaluate factors that influence health status and work disability in patients with ankylosing spondylitis (AS) in the Czech Republic. Data were collected in a retrospective fashion directly from patients with AS using mailed questionnaires containing questions regarding sociodemographic characteristics of patients, the course of their disease, therapy, rehabilitation, quality of life, and ability to work. HAQ-DI (Health Assessment Questionnaire-Disability Index) and BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) were also included in the questionnaires; 1,008 questionnaires were suitable for further statistical analysis. The average age +/- SD of patients was 50.2 +/- 10.7 years, the average symptom duration was 23.0 +/- 11.6 years. Mean time from first symptoms to diagnosis was 9.1 years. Full disability had been awarded to 303 patients (30%) at some point of their disease. Twenty seven percent of patients reported receiving full disability pension for 10 or more years. Four hundred fifty six subjects (45%) were currently or had been previously receiving partial disability pension. Receiving disability pension was more frequent among men (64%) compared to women (56%) (P = 0.012), despite the fact that women had higher BASDAI (P < 0.001) and HAQ-DI (P = 0.004) scores. Patients with a family history of AS had higher BASDAI and HAQ-DI scores (P = 0.001 and P = 0.008, respectively) compared to patients without a family history of AS. BASDAI and HAQ-DI scores correlated with age and duration of illness, younger patients and those with shorter disease duration had lower values. Fifty eight percent of patients reported a BASDAI score > or =4 (current cutoff value for initiation of biological therapy), but only 1% of patients were treated by anti TNF alpha agents within the last year. Seven hundred ninety one patients underwent spa treatment in the previous year; 96% of them experienced improvement of their health condition.

Entities:  

Mesh:

Year:  2008        PMID: 18247079     DOI: 10.1007/s10067-008-0845-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  41 in total

1.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

Review 2.  Quality of life in patients with ankylosing spondylitis.

Authors:  M M Ward
Journal:  Rheum Dis Clin North Am       Date:  1998-11       Impact factor: 2.670

3.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

4.  Effect of ankylosing spondylitis on health-related quality of life and different aspects of social life in young patients.

Authors:  Ahmet Ozgül; Fatma Peker; M Ali Taskaynatan; A Kenan Tan; Kemal Dinçer; Tunç Alp Kalyon
Journal:  Clin Rheumatol       Date:  2005-08-10       Impact factor: 2.980

5.  Familial versus sporadic ankylosing spondylitis. Two different diseases?

Authors:  A Calin; L G Kennedy; L Edmunds; R Will
Journal:  Arthritis Rheum       Date:  1993-05

6.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

7.  Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; A Spoorenberg; H Schouten; M Rutten-van Mölken; F Guillemin; M Dougados; H Mielants; K de Vlam; H van der Tempel; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

8.  Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures.

Authors:  Hanne Dagfinrud; Nina K Vollestad; Jon H Loge; Tore K Kvien; Anne Marit Mengshoel
Journal:  Arthritis Rheum       Date:  2005-02-15

9.  Costs and quality of life of patients with ankylosing spondylitis in Canada.

Authors:  Gisela Kobelt; Patrik Andlin-Sobocki; Walter P Maksymowych
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

10.  Predictors of longterm outcome in ankylosing spondylitis.

Authors:  Michele F Doran; Sinead Brophy; Kirsten MacKay; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2003-02       Impact factor: 4.666

View more
  8 in total

1.  Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors.

Authors:  Semra Yigit; Zerrin Sahin; Saliha Eroglu Demir; Deniz Hatun Aytac
Journal:  Rheumatol Int       Date:  2012-01-05       Impact factor: 2.631

2.  Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis.

Authors:  Cesar Ramos-Remus; Guillermo Hernandez-Rios; Sergio Duran-Barragan; Adriana Sanchez-Ortiz; Francisco Javier Aceves-Avila; Jose Dionisio Castillo-Ortiz; Oscar Gonzalez-Perez
Journal:  Clin Rheumatol       Date:  2011-01-06       Impact factor: 2.980

3.  Angiotensin-Receptor Blockade Improves Inflammation and Endothelial Dysfunction in Ankylosing Spondylitis: ARB-AS Study.

Authors:  Nidhi Garg; Pawan Krishan; Ashit Syngle
Journal:  Int J Angiol       Date:  2021-01-29

4.  Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis.

Authors:  Vladislava Vesović-Potić; Dusan Mustur; Dejana Stanisavljević; Tatjana Ille; Mihailo Ille
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

5.  The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008.

Authors:  Alena Petříková; Tomáš Doležal; Jiří Klimeš; Milan Vocelka; Liliana Sedová; Jozef Kolář
Journal:  Rheumatol Int       Date:  2013-01-13       Impact factor: 2.631

6.  Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis.

Authors:  K Bubová; K Prajzlerová; H Hulejová; M Gregová; K Mintálová; M Hušáková; Š Forejtová; M Filková; M Tomčík; J Vencovský; K Pavelka; L Šenolt
Journal:  Physiol Res       Date:  2020-06-25       Impact factor: 1.881

7.  Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort.

Authors:  Manouk de Hooge; Roberta Ramonda; Mariagrazia Lorenzin; Paola Frallonardo; Leonardo Punzi; Augusta Ortolan; Andrea Doria
Journal:  Arthritis Res Ther       Date:  2016-11-16       Impact factor: 5.156

Review 8.  Diagnostic delay in axial spondyloarthritis: a systematic review.

Authors:  Charles A Hay; Jon Packham; Sarah Ryan; Christian D Mallen; Alexandros Chatzixenitidis; James A Prior
Journal:  Clin Rheumatol       Date:  2022-02-19       Impact factor: 3.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.